NCT01469988 The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial Status TERMINATED Phase PHASE2
NCT01467232 IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting Status COMPLETED Phase PHASE2
NCT01466621 Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients Status COMPLETED Phase N/A
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Status UNKNOWN Phase PHASE2/PHASE3
NCT01463267 Study of Reminding to Improve Medication Adherence in Heart Failure Status COMPLETED Phase NA
NCT01461629 Self-management and Cognitive Function in Adults With Heart Failure Status COMPLETED Phase N/A
NCT01459744 An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations Status COMPLETED Phase NA
NCT01457170 Effects of Apelin on the Lung Circulation in Pulmonary Hypertension Status UNKNOWN Phase NA
NCT01452802 Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management Status COMPLETED Phase N/A
NCT01446796 Right Ventricular (RV) Pacing in Early Post-operative Continuous Flow Left Ventricular Assist Device (LVAD) Status TERMINATED Phase PHASE4
NCT01446705 Evaluation of VLER-Indiana Health Information Exchange Demonstration Project Status COMPLETED Phase N/A
NCT01444872 Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction Status COMPLETED Phase PHASE1
NCT01442129 The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation Status COMPLETED Phase PHASE2
NCT01440517 Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction Status TERMINATED Phase PHASE2
NCT01439009 Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients Status COMPLETED Phase PHASE4
NCT01438086 Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack Status COMPLETED Phase PHASE1/PHASE2